Share Twitter Facebook LinkedIn Email Briumvi is now commercially available for patients with active, relapsing forms of MS in Europe, where it is marketed by Neuraxpharm. Read More
Tesla Rival Nio Accelerates Global Expansion, To Launch EVs in Middle East Amid EU Tariff ConcernsOctober 5, 2024